317 related articles for article (PubMed ID: 26355862)
1. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract][Full Text] [Related]
2. Copy number variation profile in noninvasive prenatal testing (NIPT) can identify co-existing maternal malignancies: Case reports and a literature review.
Ji X; Chen F; Zhou Y; Li J; Yuan Y; Mo Y; Liu Q; Tseng JY; Shih-Chieh Lin D; Shen SH; Liu Y; Ye W; Cheung YN; Yuen KY; Lin S; Fu M; Zhang H; Liu N; Wang J; Yang H; Wang Y; Li S; Fan S; Jin X; Mao M; Sung PL
Taiwan J Obstet Gynecol; 2018 Dec; 57(6):871-877. PubMed ID: 30545544
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
[TBL] [Abstract][Full Text] [Related]
4. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
[TBL] [Abstract][Full Text] [Related]
5. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
[TBL] [Abstract][Full Text] [Related]
6. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
7. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.
Yin AH; Peng CF; Zhao X; Caughey BA; Yang JX; Liu J; Huang WW; Liu C; Luo DH; Liu HL; Chen YY; Wu J; Hou R; Zhang M; Ai M; Zheng L; Xue RQ; Mai MQ; Guo FF; Qi YM; Wang DM; Krawczyk M; Zhang D; Wang YN; Huang QF; Karin M; Zhang K
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14670-5. PubMed ID: 26554006
[TBL] [Abstract][Full Text] [Related]
9. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations.
Lenaerts L; Che H; Brison N; Neofytou M; Jatsenko T; Lefrère H; Maggen C; Villela D; Verheecke M; Dehaspe L; Croitor A; Hatse S; Wildiers H; Neven P; Vandecaveye V; Floris G; Vermeesch JR; Amant F
Clin Chem; 2020 Nov; 66(11):1414-1423. PubMed ID: 33141904
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?
Prasad V
Eur J Cancer; 2015 Nov; 51(16):2272-4. PubMed ID: 26278647
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma.
Wong FC; Lo YM
Annu Rev Med; 2016; 67():419-32. PubMed ID: 26473414
[TBL] [Abstract][Full Text] [Related]
13. Prenatal testing can detect occult cancer in pregnant women.
Tanday S
Lancet Oncol; 2015 Aug; 16(8):e383. PubMed ID: 26190750
[No Abstract] [Full Text] [Related]
14. Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing.
Wang S; Huang S; Ma L; Liang L; Zhang J; Zhang J; Cram DS
Clin Chim Acta; 2015 Apr; 444():113-6. PubMed ID: 25689220
[TBL] [Abstract][Full Text] [Related]
15. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.
Lenaerts L; Van Calsteren K; Che H; Vermeesch JR; Amant F
Prenat Diagn; 2019 Nov; 39(12):1162-1165. PubMed ID: 31393011
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
Skrzypek H; Hui L
Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal detection of aneuploidy.
Robinson C; van den Boom D; Bombard AT
Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma in pregnancy presenting as multiple aneuploidy on non-invasive prenatal testing.
Tan XN; Harrup R
Intern Med J; 2017 May; 47(5):601-602. PubMed ID: 28503877
[No Abstract] [Full Text] [Related]
19. Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma.
Dharajiya N; Zwiefelhofer T; Guan X; Angkachatchai V; Saldivar JS
Curr Protoc Hum Genet; 2015 Jan; 84():8.15.1-8.15.20. PubMed ID: 25599670
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
Shi X; Zhang Z; Cram DS; Liu C
Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
